Seegene Receives FDA Emergency Authorization for Skin Ulcer Test

Seegene wins FDA emergency authorization for skin ulcer test

Seegene said Tuesday that its US subsidiary has received emergency use authorization from the US Food and Drug Administration for a molecular diagnostic test that can simultaneously detect four viruses associated with similar skin and mucosal lesions. The Allplex HSV-1&2/VZV/MPXV Assay is a syndromic real-time polymerase chain reaction test developed by Seegene USA. It detects herpes simplex virus types 1 and 2, varicella-zoster virus and the virus that causes mpox in a single test. The company

By The Korea Herald